Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HYPR Stock Forecast 2026-2027
$1.12
Current Price
$111.18M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to HYPR Price Targets
+124.2%
To High Target of $2.50
+79.4%
To Median Target of $2.00
+79.4%
To Low Target of $2.00
HYPR Price Momentum
-13.8%
1 Week Change
-21.1%
1 Month Change
+41.8%
1 Year Change
+14.3%
Year-to-Date Change
-49.8%
From 52W High of $2.22
+46.7%
From 52W Low of $0.76
📊 TOP ANALYST CALLS
Did HYPR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Hyperfine is one of their latest high-conviction picks.
Latest HYPR Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, HYPR has a bullish consensus with a median price target of $2.00 (ranging from $2.00 to $2.50). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.12, the median forecast implies a 79.4% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Marie Thibault at BTIG, suggesting a 79.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HYPR Analyst Ratings
2
Buy
0
Hold
0
Sell
HYPR Price Target Range
Low
$2.00
Average
$2.00
High
$2.50
Current: $1.12
Latest HYPR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HYPR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 29, 2026 | BTIG | Marie Thibault | Buy | Initiates | $2.00 |
| Mar 19, 2026 | Lake Street | Buy | Maintains | $N/A | |
| Aug 15, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Aug 14, 2025 | Lake Street | Buy | Maintains | $N/A | |
| May 15, 2025 | B. Riley Securities | Buy | Maintains | $N/A | |
| May 14, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Mar 24, 2025 | Lake Street | Buy | Initiates | $N/A | |
| Mar 20, 2025 | B. Riley Securities | Buy | Maintains | $N/A | |
| Mar 18, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Mar 22, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Nov 30, 2023 | Jefferies | Hold | Initiates | $N/A | |
| Aug 15, 2023 | B. Riley Securities | Buy | Maintains | $N/A | |
| Mar 22, 2023 | B. Riley Securities | Buy | Maintains | $N/A | |
| Oct 4, 2022 | B. Riley Securities | Buy | Initiates | $N/A | |
| Aug 11, 2022 | Wells Fargo | Equal-Weight | Downgrade | $N/A | |
| May 31, 2022 | Evercore ISI Group | Outperform | Initiates | $N/A | |
| Apr 14, 2022 | Wells Fargo | Overweight | Initiates | $N/A |
Hyperfine Inc. (HYPR) Competitors
The following stocks are similar to Hyperfine based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Hyperfine Inc. (HYPR) Financial Data
Hyperfine Inc. has a market capitalization of $111.18M with a P/E ratio of -2.6x. The company generates $15.33M in trailing twelve-month revenue with a -226.9% profit margin.
Revenue growth is +82.6% quarter-over-quarter, while maintaining an operating margin of -219.3% and return on equity of -89.8%.
Valuation Metrics
Market Cap
$111.18M
Enterprise Value
$83.28M
P/E Ratio
-2.6x
PEG Ratio
0.1x
Price/Sales
7.2x
Growth & Margins
Revenue Growth (YoY)
+82.6%
Gross Margin
+50.7%
Operating Margin
-219.3%
Net Margin
-226.9%
EPS Growth
+82.6%
Financial Health
Cash/Price Ratio
+36.9%
Current Ratio
5.5x
Debt/Equity
38.9x
ROE
-89.8%
ROA
-38.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Hyperfine Inc. (HYPR) Business Model
About Hyperfine Inc.
What They Do
Develops portable, low-cost MRI systems.
Business Model
Hyperfine Inc. generates revenue by selling its innovative Swoop Portable MRI systems to healthcare providers, enhancing patient care with real-time, bedside imaging. The company's focus on affordability and accessibility allows it to target a broad market, including emergency rooms and remote areas lacking traditional MRI facilities.
Additional Information
Hyperfine's technology is set to transform healthcare delivery by improving access to advanced imaging solutions, which could lead to faster diagnoses and better patient outcomes. Its emphasis on innovation positions the company as a significant player in the med-tech industry, with potential to impact hospital operations and patient management protocols globally.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
102
CEO
Ms. Maria Degois-Sainz
Country
United States
IPO Year
2021
Website
www.hyperfinemri.comHyperfine Inc. (HYPR) Latest News & Analysis
Latest News
Quick Summary
Hyperfine has launched its next-gen Swoop® system in Europe, marking the start of global expansion for its advanced portable MRI technology.
Why It Matters
Hyperfine's launch of its next-gen Swoop® system in Europe signals growth potential and market expansion, which could drive revenue and enhance competitiveness in the medical imaging sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Neurosurgeons will guide the implementation of the Swoop® system in neurosurgical care, focusing on workflow, product capabilities, and supporting evidence.
Why It Matters
The involvement of leading neurosurgeons in guiding the Swoop® system enhances its credibility and potential adoption, which could positively impact the company's market position and financial performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Hyperfine reports increased adoption of its Swoop® system in key hospitals and neurology clinics across the US, achieving significant scan volume milestones.
Why It Matters
Hyperfine's Swoop® system gaining traction signals increased market penetration, potentially boosting revenue and market share, which can positively influence stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
1 month ago
Quick Summary
Hyperfine, Inc. (HYPR) presented at the Jefferies Global Healthcare Conference, sharing insights and updates on their business strategy and performance.
Why It Matters
Hyperfine's presentation at a major healthcare conference can indicate its growth potential and innovations, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Hyperfine is set to be included in the Russell 3000® and Russell 2000® Indexes following the June 2026 Russell Reconstitution.
Why It Matters
Hyperfine's inclusion in the Russell 3000 and Russell 2000 indices may increase its visibility and attract institutional investment, potentially boosting its stock price.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The PRIME study indicates that bedside portable MRI reduces order-to-scan time compared to conventional MRI and effectively identifies critical findings in the emergency department.
Why It Matters
The PRIME study indicates that portable MRI technology improves efficiency in emergency settings, potentially enhancing patient outcomes and driving demand for innovative medical imaging solutions.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About HYPR Stock
What is Hyperfine Inc.'s (HYPR) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Hyperfine Inc. (HYPR) has a median price target of $2.00. The highest price target is $2.50 and the lowest is $2.00.
Is HYPR stock a good investment in 2027?
According to current analyst ratings, HYPR has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.12. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HYPR stock?
Wall Street analysts predict HYPR stock could reach $2.00 in the next 12 months. This represents a 79.4% increase from the current price of $1.12. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Hyperfine Inc.'s business model?
Hyperfine Inc. generates revenue by selling its innovative Swoop Portable MRI systems to healthcare providers, enhancing patient care with real-time, bedside imaging. The company's focus on affordability and accessibility allows it to target a broad market, including emergency rooms and remote areas lacking traditional MRI facilities.
What is the highest forecasted price for HYPR Hyperfine Inc.?
The highest price target for HYPR is $2.50 from at , which represents a 124.2% increase from the current price of $1.12.
What is the lowest forecasted price for HYPR Hyperfine Inc.?
The lowest price target for HYPR is $2.00 from Marie Thibault at BTIG, which represents a 79.4% increase from the current price of $1.12.
What is the overall HYPR consensus from analysts for Hyperfine Inc.?
The overall analyst consensus for HYPR is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.00.
How accurate are HYPR stock price projections?
Stock price projections, including those for Hyperfine Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 9, 2026 8:54 PM UTC